Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Sorrento Therpt
(NQ:
SRNE
)
10.50
USD
+1.07 (+11.35%)
Streaming Delayed Price
Updated: 5:27 AM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Sorrento Therpt
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Sorrento Provides Status Update on the Cynviloq™ Registrational TRIBECA™ Study
January 12, 2015
From
PR Newswire
Conkwest, Sorrento And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong
January 06, 2015
From
PR Newswire
Sorrento To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco
January 05, 2015
From
PR Newswire
Conkwest Appoints Robert Rosen and Henry Ji to its Board of Directors
December 29, 2014
From
Business Wire News Releases
Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board
December 24, 2014
From
PR Newswire
Sorrento and Conkwest Announce Exclusive Global Collaboration
December 18, 2014
Developing Next Generation Cancer Immunotherapy with "Off-the-Shelf" Chimeric Antigen Receptor-Tumor Attacking Natural Killer (CAR-TNK™) Cell Lines
From
PR Newswire
Sorrento Announces Strategic Investment By And Collaboration With Nantworks Founder Dr. Patrick Soon-Shiong For The Advancement Of Cancer Immunotherapies
December 15, 2014
From
PR Newswire
Sorrento Therapeutics Announces Poster Presentations on its Anti-c-Met/PD-L1 Bispecific Antibodies and Anti-c-Met-Antibody Drug Conjugate at the 37th Annual San Antonio Breast Cancer Symposium
December 08, 2014
From
PR Newswire
Sorrento To Present At The 2014 Oppenheimer Healthcare Conference
December 03, 2014
From
PR Newswire
Sorrento To Present At The 2014 Stifel Healthcare Conference
November 12, 2014
From
PR Newswire
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis
November 05, 2014
From
Marketwired News Releases
BTV Episode #300 Featuring Gilead, Cynapsus and biOasis
November 05, 2014
From
Marketwired
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel
October 14, 2014
From
PR Newswire
Sorrento and Lee's Pharmaceutical Enter into Exclusive China Licensing Agreement to Develop and Commercialize Anti-PD-L1 antibody
October 03, 2014
From
PR Newswire
Sorrento Therapeutics to Present at Two Healthcare Conferences
September 05, 2014
From
PR Newswire
Sorrento Awarded NIH Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF)
August 26, 2014
From
PR Newswire
Data Published by Researchers from The Scripps Research Institute Demonstrate Potential for MYC Inhibitor Licensed by Sorrento Therapeutics
August 18, 2014
Proceedings of the National Academy of Sciences Study Shows Ability to Create Therapeutics Targeting Critical MYC Regulator for Potential Treatment of Cancer
From
PR Newswire
Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
August 11, 2014
From
Business Wire News Releases
Sorrento Therapeutics Appoints Douglas Ebersole to its Board of Directors
August 08, 2014
From
PR Newswire
Sorrento Therapeutics, Fast-Tracked for FDA Approval, CEO Clip Video
August 06, 2014
From
Newsfile Corp News Releases
Sorrento Announces the Unexpected Death of its Chief Business Officer
July 31, 2014
From
PR Newswire
Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor
July 21, 2014
From
PR Newswire
San Diego Sleeper Fast-Tracked for FDA Approval
July 07, 2014
From
Newsfile Corp News Releases
Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates
July 01, 2014
From
PR Newswire
BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers
June 25, 2014
From
Marketwired News Releases
BTV Reports on Roche, Sorrento Therapeutics Takes on a Goliath, Plus Biotech Up-and-Comers
June 25, 2014
From
Marketwired
Morphotek and Sorrento Therapeutics Sign an Exclusive Research and Option Agreement to Generate and Develop Morphotek Antibody Drug Conjugates
June 25, 2014
From
PR Newswire
Sorrento Therapeutics Announces Confidential Submission of Draft Registration Statement for Initial Public Offering (IPO) of its Wholly-owned Subsidiary Ark Animal Health with the SEC
June 23, 2014
From
PR Newswire
Sorrento to Present at BIO Business Forum
June 20, 2014
From
PR Newswire
Sorrento Announces Underwriters' Exercise of Over-Allotment Option
June 12, 2014
From
PR Newswire
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.